OptiBiotix Health Plc (LON:OPTI – Get Free Report) insider Stephen O’Hara purchased 50,000 shares of OptiBiotix Health stock in a transaction on Monday, September 22nd. The stock was bought at an average price of GBX 10 per share, with a total value of £5,000.
Stephen O’Hara also recently made the following trade(s):
Get OptiBiotix Health alerts:
On Tuesday, September 23rd, Stephen O’Hara purchased 95,238 shares of OptiBiotix Health stock. The stock was bought at an average price of GBX 11 per share, with a total value of £10,476.18.
OptiBiotix Health Trading Down 0.3%
LON:OPTI opened at GBX 10.22 on Thursday. OptiBiotix Health Plc has a 12-month low of GBX 9 and a 12-month high of GBX 23.50. The stock has a 50-day moving average price of GBX 11 and a 200 day moving average price of GBX 13.90. The stock has a market capitalization of £10.56 million, a P/E ratio of -555.43 and a beta of 1.71.
OptiBiotix Health (LON:OPTI – Get Free Report) last released its earnings results on Tuesday, September 16th. The company reported GBX (1.15) earnings per share (EPS) for the quarter. OptiBiotix Health had a negative return on equity of 36.76% and a negative net margin of 524.43%.
OptiBiotix Health Company Profile
(Get Free Report)
OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.
Featured Stories
Five stocks we like better than OptiBiotix Health
What Do S&P 500 Stocks Tell Investors About the Market?
Cybersecurity Market Set to Double: This ETF Offers Exposure
Where to Find Earnings Call Transcripts
Downgraded But Not Done: 3 Stocks Ready for a Market Comeback
Unveiling The Power Of VWAP: A Key Indicator For Traders
Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It Coming
